Non-insulin-dependent diabetes mellitus (Type II diabetes). Adults, initial: 1-2 mg once daily, given with breakfast or the first main meal. The initial dose should be 1 mg in those sensitive to hypo-glycemic drugs, in those with impaired renal or hepatic function, and in elderly, debilitated, or malnourished clients. The maximum initial dose is 2 mg or less daily. Maintenance: 1-4 mg once daily up to a maximum of 8 mg once daily. After a dose of 2 mg is reached, the dose should be increased in increments of 2 mg or less at 1- to 2-week intervals (determined by the blood glucose response). When combined with insulin therapy: 8 mg once daily with the first main meal with low-dose insulin. The fasting glucose level for beginning combination therapy is greater than 150 mg/dL glucose in the plasma or serum.

Type II diabetes—transfer from other hypoglycemic agents. When transferring clients to glim-ipiride, no transition period is required. However, clients should be observed closely for 1 to 2 weeks for hypoglycemia when being transferred from longer half-life sulfony-lureas (e.g., chlorpropamide) to glimepiride.

Delicious Diabetic Recipes

Delicious Diabetic Recipes

This brilliant guide will teach you how to cook all those delicious recipes for people who have diabetes.

Get My Free Ebook

Post a comment